In a new clinical practice guideline, the Endocrine Society advises universal screening of those with hypertension by ...

The primary endpoint was functional immune tolerance, defined as off all immunosuppressive drugs 24 months after ...

With investors and drugmakers increasingly eyeing the kidney disease space, a new company hopes to shed its underdog status ...

A recent study led by Paul DeCaen, Ph.D., associate professor of Pharmacology, has identified novel molecular mechanisms by ...

An East Bay startup led by a former 23andMe exec snags $54.5 million to target a deadly kidney disease.

Most individuals with chronic kidney disease (CKD) are unaware of their disease, according to a KDIGO controversies conference on CKD prevention.

Finerenone may lower risks for kidney and cardiovascular events for adults with chronic kidney disease and type 2 diabetes, ...

Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

The company raised $54.5 million to make treatments that restore protein function in polycystic kidney disease ...

Long-term exposure to water contaminants, even below the regulatory limits, significantly increases the risk of chronic ...

Researchers conducted a post hoc analysis of the SURMOUNT-1 trial to assess the effect of tirzepatide on kidney function in prediabetes with obesity or overweight.

Nursing care plans for CKD help monitor and manage disease progression by providing guidelines for identifying and resolving kidney-related issues. Learn more.